A Trial of Tisotumab Vedotin in Cervical Cancer
Public ClinicalTrials.gov record NCT03438396. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
Study identification
- NCT ID
- NCT03438396
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2018
- Primary completion
- Feb 5, 2020
- Completion
- Aug 1, 2022
- Last update posted
- Jul 24, 2023
2018 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Arizona Oncology Associate - Biltmore Cancer Center | Phoenix | Arizona | 85016 | — |
| UCLA Dept. of OBGYN | Los Angeles | California | 90095 | — |
| Southern Baptist Hospital of Florida, Inc | Jacksonville | Florida | 32258 | — |
| University of Miami Miller School of Medicine | Miami | Florida | 33136 | — |
| University of Gynecologic Oncology | Atlanta | Georgia | 30342 | — |
| Community Hospital East | Indianapolis | Indiana | 46219 | — |
| Louisville Oncology | Louisville | Kentucky | 40207 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01105 | — |
| Women's Cancer Center of Nevada | Las Vegas | Nevada | 89169 | — |
| MD Anderson Cancer Center at Cooper University Hospital | Camden | New Jersey | 08103 | — |
| University of New Mexico Comprehensive Cancer Center (UNMCCC) | Albuquerque | New Mexico | 87102 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| The Ohio State University Wexner Medical Center | Hilliard | Ohio | 43210 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Oklahoma Cancer Specialists and Research Institute, LLC | Tulsa | Oklahoma | 74146 | — |
| Abington Memorial Hospital | Willow Grove | Pennsylvania | 19090 | — |
| Bon Secours Saint Francis Cancer Center | Greenville | South Carolina | 29607 | — |
| UT Health McGovern Medical School | Houston | Texas | 77030 | — |
| Froedtert & Medical College Clinics | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03438396, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03438396 live on ClinicalTrials.gov.